Search

Search Results
Results 3641 - 3650 of 3701 for Absorption
  • Zimybe
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zimybe intended for persons living in Australia.
  • Pyralin EN
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Pyralin EN intended for persons living in Australia.
  • Salazopyrin
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Tetrabenazine
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Tetrabenazine intended for persons living in Australia.
  • Agrylin
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Agrylin intended for persons living in Australia.
  • Deferasirox-Teva
    Drug - 13 Oct 2021
    Consumer Medicine Information (CMI) about Deferasirox-Teva intended for persons living in Australia.
  • Research into the laser particle size analysis of the Domperidone API
    White Paper - 2 Aug 2021
    Domperidone is a synthetic benzimidazole derivative. It functions as a dopamine receptor blocker and is utilized for a variety of gastric issues. While there are clear regulations on particle sizing...
  • Rocaltrol
    Drug - 15 Apr 2021
    Consumer Medicine Information (CMI) about Rocaltrol intended for persons living in Australia.
  • Zatamil
    Drug - 1 Nov 2020
    Consumer Medicine Information (CMI) about Zatamil intended for persons living in Australia.
  • Rancimat Method for the Oxidation Stability of Fats and Oils
    White Paper - 21 Aug 2019
    Using the rancimat method to determine the oxidation stability of fats and oils as an accelerated ageing test.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback